Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 9, 2019
English
Sofia, Bulgaria, December 5, 2019 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for November 2019 the Company recorded an increase in sales of 24% compared to the same month of 2018, incl. 21% increase in sales for the domestic market and 27% increase in export sales.